IPAMORELIN
Growth Hormone Secretagogue Research Peptide
For Research Use Only
Overview
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue (GHS). It has been studied for its interaction with the ghrelin/growth hormone secretagogue receptor (GHS-R1a) and its ability to stimulate growth hormone release in experimental models.
Ipamorelin has attracted research interest because early studies suggest a comparatively selective effect on growth hormone signaling, making it useful for investigating the GH/IGF-1 axis, pituitary physiology, metabolism, and endocrine signaling.
Research Areas
Ipamorelin has been investigated primarily in preclinical and experimental research involving:
- Growth hormone secretion
- GH/IGF-1 signaling
- Pituitary physiology
- Ghrelin receptor activity
- Endocrine signaling
- Metabolic regulation
- Body-composition research
- Skeletal-muscle physiology
- Bone biology
- Recovery and tissue-remodeling models
Ipamorelin remains an investigational compound and is not an FDA-approved treatment.
Mechanism Being Studied
Researchers investigate Ipamorelin primarily for its activity at the GHS-R1a receptor, also known as the ghrelin receptor.
Activation of this receptor can signal the pituitary gland to release growth hormone. Areas under investigation include:
- Stimulation of pulsatile GH secretion
- Downstream IGF-1 signaling
- Pituitary growth-hormone regulation
- Ghrelin-receptor signaling
- Metabolic pathways associated with the GH axis
- Endocrine feedback mechanisms
Ipamorelin’s receptor profile is one reason researchers compare it with other growth-hormone secretagogues.
Why Researchers Study Ipamorelin
Growth hormone participates in numerous biological processes involving growth, metabolism, tissue remodeling, and endocrine regulation.
Ipamorelin provides researchers with another method of investigating the body’s endogenous growth-hormone signaling system rather than supplying recombinant growth hormone directly.
Research areas of particular interest include:
- GH secretion dynamics
- IGF-1 physiology
- Pituitary function
- Metabolic signaling
- Muscle and connective-tissue biology
- Bone physiology
- Endocrine regulation
Product Features
✔ Premium Research Grade
✔ High-Purity Lyophilized Peptide
✔ Third-Party Tested (COA Available)
✔ Identity & Purity Verification
✔ Secure Professional Packaging
✔ Laboratory Research Only
Common Research Applications
Researchers have explored Ipamorelin in studies involving:
- Growth-hormone physiology
- GH/IGF-1 signaling
- Ghrelin-receptor research
- Endocrine biology
- Metabolic research
- Skeletal-muscle physiology
- Bone metabolism
- Pituitary signaling
- Cellular and tissue-remodeling models
Storage
- Store according to the product’s batch-specific stability documentation.
- Protect lyophilized material from excessive heat, moisture, and direct sunlight.
- Following preparation for laboratory experiments, use validated laboratory storage procedures.
- Minimize unnecessary temperature cycling and repeated freeze-thaw exposure.
Disclaimer
For Research Use Only.
This product is intended exclusively for laboratory research and analytical purposes.
Ipamorelin is not approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, cure, or prevention of disease and is not intended for human or veterinary use.
Why Choose Voltis Research Co.
At Voltis Research Co., our focus is simple: provide researchers with dependable compounds backed by quality control, analytical transparency, and consistency.
Qualifying batches undergo independent third-party analytical testing, with batch-specific Certificates of Analysis available to document product identity and purity.
The Voltis Commitment
⚡ Research-Grade Quality
⚡ Independent Third-Party Testing
⚡ Batch-Specific Certificate of Analysis (COA)
⚡ High-Purity Lyophilized Peptides
⚡ Rigorous Quality Control
⚡ Secure Professional Packaging
⚡ Transparency, Consistency & Reliability
Powering Discovery Through Quality Research.
Ipamorelin (5 mg Vial) Dosage Protocol
